How is dilated cardiomyopathy managed?
Doctors usually treat dilated cardiomyopathy with a combination of medications. Depending on your symptoms, you might need two or more drugs. Drugs that are used to treat heart failure and dilated cardiomyopathy include: Angiotensin-converting enzyme (ACE) inhibitors.
Can you live 10 years with dilated cardiomyopathy?
About 30% will survive for 10 years.
What is the treatment for nonischemic cardiomyopathy?
Current surgical options for treatment of NICM include mitral valve annuloplasty, cardiac support devices, mechanical circulatory support devices, and cardiac transplantation.
Can you recover from dilated cardiomyopathy?
Although the long term prognosis of patients with dilated cardiomyopathy (DCM) remains poor, approximately 25% of DCM patients with recent onset of heart failure (< 6 months) have a relatively benign clinical course with a spontaneously improvement in symptoms and partial, or in some cases complete, recovery of left …
Is dilated cardiomyopathy serious?
Dilated cardiomyopathy might not cause symptoms, but for some people it can be life-threatening. It’s a common cause of heart failure. Dilated cardiomyopathy can also lead to irregular heartbeats (arrhythmias), blood clots or sudden death. The condition can affect anyone, including infants and children.
How long can I live with dilated cardiomyopathy?
Clinically, DCM is characterized by a progressive course of ventricular dilatation and systolic dysfunction. The life expectancy is limited and varies according to the underlying etiology with a median survival time of about 5 years after diagnosis.
How bad is dilated cardiomyopathy?
How long can you live with dilated cardiomyopathy?
What is the treatment for Takayasu’s arteritis?
Treatment of Takayasu’s arteritis focuses on controlling the inflammation with medications and preventing further damage to your blood vessels.
What is targettakayasu arteritis?
Takayasu arteritis is a well known yet rare form of large vessel vasculitis. This review details the history, clinical features, differential diagnoses, classification, and immunology of the disorder. Suppression of inflammation and preservation of vascular competence are the aims of treatment.
Can labor analgesia be managed in advanced Takayasu aortoarteritis with dilated cardiomyopathy?
We describe the management of labor analgesia in a symptomatic parturient suffering from advanced Takayasu aortoarteritis with dilated cardiomyopathy and a recent episode of congestive cardiac failure. The patient was man-aged with graded epidural analgesia instituted early in labor.
Can methotrexate be used as a steroid sparing drug in Takayasu arteritis?
Larger studies will be necessary to confirm these findings and establish the place of this drug in the treatment of Takayasu arteritis. Currently, the best evidence based treatments include steroids, to which 50% respond, and methotrexate to which a further 50% respond. The use of methotrexate as a steroid sparing drug is logical and safe.